2023年12月-至今：研究員，課題組長，中國科學(xué)院上海有機(jī)所-生命過程小分子調(diào)控全國重點(diǎn)實(shí)驗(yàn)室
2017年7月-2023年12月：Principal Investigator，博士生導(dǎo)師，終身教職（高級(jí)職稱），英國埃克塞特大學(xué)醫(yī)學(xué)院（英格蘭）
2016年7月-2017年6月：Research Investigator, 英國醫(yī)學(xué)研究理事會(huì)（MRC）蛋白質(zhì)磷酸化與泛素化研究所（PPU）,英國鄧迪大學(xué)（蘇格蘭）
2015年7月-2016年6月：Research Investigator, 耶魯大學(xué)醫(yī)學(xué)院，美國康涅狄格州紐黑文市
2011年7月-2015年6月：博士后研究員，英國醫(yī)學(xué)研究理事會(huì)（MRC）蛋白質(zhì)磷酸化與泛素化研究所（PPU）,英國鄧迪大學(xué)（蘇格蘭）
2008年3月-2011年5月：博士研究生，生物化學(xué)專業(yè)，英國紐卡斯?fàn)柎髮W(xué)（英格蘭）
2004年9月-2007年7月：碩士研究生，海洋生物學(xué)專業(yè)，國家海洋局第三海洋研究所
1999年9月-2003年7月：本科學(xué)生，生物工程專業(yè)，福建師范大學(xué)生命科學(xué)學(xué)院
主要研究方向
1.?研究主要集中在細(xì)胞信號(hào)轉(zhuǎn)導(dǎo)和藥物作用機(jī)制上。探究激酶、轉(zhuǎn)錄因子、離子通道、離子共轉(zhuǎn)運(yùn)蛋白等在信號(hào)傳導(dǎo)中的作用，比如WNK-SPAK和TLR4-NF-κB通路，也研究離子共轉(zhuǎn)運(yùn)蛋白（CCCs，SLC12家族，包括SLC12A1?(NKCC2)、SLC12A2?(NKCC1)、SLC12A3?(NCC)、SLC12A5?(KCC2)、SLC12A6?(KCC3)等成員）在維持細(xì)胞內(nèi)外鈉、鉀、氯離子穩(wěn)態(tài)與細(xì)胞膜電勢(shì)變化在細(xì)胞正常生理和各種疾病狀態(tài)（病理）中的功能。目前對(duì)多種激酶和轉(zhuǎn)運(yùn)蛋白等的細(xì)胞信號(hào)轉(zhuǎn)導(dǎo)和藥物作用機(jī)制的研究進(jìn)一步拓展到腫瘤炎癥、腫瘤微環(huán)境和免疫機(jī)制、細(xì)胞凋亡的調(diào)控，以及相關(guān)疾病的生物學(xué)特征。此外，進(jìn)行小分子藥物和天然微生物產(chǎn)物的活性分析與鑒定。這些研究旨在揭示疾病的發(fā)生和發(fā)展機(jī)制，為診斷和治療提供科學(xué)依據(jù)，并推動(dòng)新藥研發(fā)。
其他研究方向
1.?利用下一代測(cè)序技術(shù)（如外顯子測(cè)序）解析重要臨床疾病的突變分子，并通過CRISPR-Cas9等技術(shù)構(gòu)建相應(yīng)的細(xì)胞和動(dòng)物模型，以深入研究疾病生物學(xué)。
2.?在微生物研究領(lǐng)域，致力于海洋微生物新種的鑒定、工業(yè)微生物育種、及其酶的開發(fā)和發(fā)酵工程，以及篩選海洋放線菌來源的抗菌小分子活性分子。此外，研究化學(xué)難合成或化學(xué)合成成本高的長鏈不飽和脂肪酸，如EPA（二十碳五烯酸）和DHA（二十二碳六烯酸）的生物合成。
3.?在綠色能源領(lǐng)域，包括對(duì)電化學(xué)和微生物電池的研究開發(fā)。
Fellow of the Higher Education Academy UK (FHEA, 英國高等教育學(xué)會(huì)會(huì)士)；
Fellow of the Royal Society of Biology (FRSB, 英國皇家生物學(xué)會(huì)會(huì)士)；
Member of Sigma Xi，The Scientific Research Honor Society?（美國Sigma Xi科學(xué)研究榮譽(yù)學(xué)會(huì)會(huì)員）；
2024年，Biochemical Society (英國生物化學(xué)學(xué)會(huì)) Travel Award?參加國際會(huì)議旅行獎(jiǎng)；
2021年，國家相關(guān)人才計(jì)劃；
2021年，英國埃克塞特大學(xué)“學(xué)術(shù)團(tuán)隊(duì)建設(shè)”方面獲得優(yōu)秀獎(jiǎng)；
2019年，福建省“閩江學(xué)者獎(jiǎng)勵(lì)計(jì)劃”；
2019年，英國?？巳卮髮W(xué)“科研原創(chuàng)性方面處于世界領(lǐng)先的質(zhì)量”方面獲得超越獎(jiǎng)；
2012年，英國帕金森病協(xié)會(huì)Travel Award?參加會(huì)議旅行獎(jiǎng)；
2011年，英國醫(yī)學(xué)研究理事會(huì)MRC-Career Development Award職業(yè)生涯發(fā)展獎(jiǎng)；
2010年，美國油脂化學(xué)家協(xié)會(huì)（American Oil Chemists' Society, AOCS）優(yōu)秀青年科學(xué)家獎(jiǎng)；
2010年，美國油脂化學(xué)家協(xié)會(huì)（American Oil Chemists' Society, AOCS）優(yōu)秀論文一等獎(jiǎng)；
2008年，英國政府生物技術(shù)與生物科學(xué)研究理事會(huì)（BBSRC）”多蘿西·霍奇金博士研究生獎(jiǎng)(DHPA), 全額博士獎(jiǎng)學(xué)金”（多蘿西·霍奇金為英國首位女科學(xué)家在1964年獲得諾貝爾化學(xué)獎(jiǎng)）；
2008年，國家海洋局極地研究?jī)?yōu)秀論文三等獎(jiǎng)（兩項(xiàng)研究成果)；
2006年，中國酶制劑及生物催化產(chǎn)品技術(shù)開發(fā)與產(chǎn)業(yè)化會(huì)議，獲得諾維信（Novozymes，中國)投資有限公司資助參加會(huì)議獎(jiǎng)；
2005年，福建省海洋學(xué)會(huì)優(yōu)秀論文二等獎(jiǎng)；
2005年，中國酶工程學(xué)會(huì)優(yōu)秀青年論文獎(jiǎng)；
2002年，福建省大學(xué)生創(chuàng)業(yè)大賽三等獎(jiǎng)（作為團(tuán)隊(duì)負(fù)責(zé)人）；
2001年，大學(xué)生記念建黨八十周年暨第五次鄧小平理論研討會(huì)優(yōu)秀論文三等獎(jiǎng)。
(1) Li, L.; Huang, W.; Ren, X.; Wang, Z.; Ding, K.; Zhao, L.; Zhang, J.*?Unlocking the potential: advancements and future horizons in ROR1-targeted cancer therapies. Sci China Life Sci 2024, 67(12), 2603–2616.
(2) McMoneagle, E.; Zhou, J.; Zhang, S.; Huang, W.; Josiah, S. S.; Ding, K.; Wang, Y.; Zhang, J.*?Neuronal K(+)-Cl(-) cotransporter KCC2 as a promising drug target for epilepsy treatment. Acta Pharmacol Sin 2024, 45, 1–22.??
(3) Geng, W.; Thomas, H.; Chen, Z.; Yan, Z.; Zhang, P.; Zhang, M.; Huang, W.; Ren, X.; Wang, Z.; Ding, K.; Zhang, J.*?Mechanisms of acquired resistance to HER2-Positive breast cancer therapies induced by HER3: A comprehensive review. Eur J Pharmacol 2024, 977, 176725.
(4) Trinder, A.; Ding, K.; Zhang, J.*?The therapeutic significance of HER3 in non-small cell lung cancer (NSCLC): A review study. Curr Med Chem 2024, 31:CMC-EPUB-137360.?
(5) Zhang, J.*?Microbial stars: shedding light on gut microbes' role in insulin resistance and innovative diabetes therapies. Gut Microbes 2024, 16?(1), 2307581.
(6) Zhang, J.*?Hereditary causes of hypertension due to increased sodium transport. Curr Opin Pediatr 2024, 36?(2), 211-218.
(7) Zhang, J.*;?Sabatier, J.-M.; Chahine, M.; Tricarico, D. Editorial: Reviews in pharmacology of ion channels and channelopathies. Front Pharmacol 2024, 15.
(8) Pracucci, E.; Graham, R. T.; Alberio, L.; Nardi, G.; Cozzolino, O.; Pillai, V.; Pasquini, G.; Saieva, L.; Walsh, D.; Landi, S.; Zhang, J.; et al. Daily rhythm in cortical chloride homeostasis underpins functional changes in visual cortex excitability. Nat Commun 2023, 14?(1), 7108.
(9) . Zhang, J.*?Commentaries: Lecanemab: pioneering the way as the first approved drug for Alzheimer's disease treatment. Inflamm Res 2023, 72?(9), 1873-1876.
(10) Zhang, S.; Meor Azlan, N. F.; Josiah, S. S.; Zhou, J.; Zhou, X.; Jie, L.; Zhang, Y.; Dai, C.; Liang, D.; Li, P.; et al. Zhang, J.*?The role of SLC12A family of cation-chloride cotransporters and drug discovery methodologies. J Pharm Anal 2023, 13?(12), 1471-1495.
(11) Zhang, J.*;?Hartmann, A. M.; Guo, J. Editorial: Chloride homeostasis in animal cell physiology. Front Physiol 2023, 14, 1227565.
(12) Zhang, J.*;?Wang, J.; Labes, A.; Zeng, R. Marine microbial-derived molecules and their potential medical and cosmetic applications, volume II. Front Microbiol 2023, 14, 1188008.
(13) Robert, S. M.; Reeves, B. C.; Kiziltug, E.; Duy, P. Q.; Karimy, J. K.; Mansuri, M. S.; Marlier, A.; Allington, G.; Greenberg, A. B. W.; DeSpenza, T., Jr.; Zhang, J.;?et al. The choroid plexus links innate immunity to CSF dysregulation in hydrocephalus. Cell 2023, 186?(4), 764-785 e721.
(14) Zhang, J.*;?Siew, K.; Sun, D. Targeting pumps, channels and transporters for the treatments of vascular, cardiovascular and kidney diseases. Front Pharmacol 2023, 14, 1130882.
(15) Josiah, S. S.; Meor Azlan, N. F.; Oguro-Ando, A.; Zhang, J.*?Study of the functions and activities of neuronal K-Cl co-transporter KCC2 using western blotting. J Vis Exp 2022, ?(190), e64179.
(16) Kury, S.*; Zhang, J.*; Besnard, T.; Caro-Llopis, A.; Zeng, X.; Robert, S. M.; Josiah, S. S.; Kiziltug, E.; Denomme-Pichon, A. S.; Cogne, B.; et al. Rare pathogenic variants in WNK3 cause X-linked intellectual disability. Genet Med 2022, 24?(9), 1941-1951.
(17) D’Silva, E.; Meor Azlan, N. F.; Zhang, J.*?Angiotensin II Receptor Blockers in the Management of Hypertension in Preventing Cognitive Impairment and Dementia—A Systematic Review. Pharmaceutics 2022, 14?(10).
(18) Zhang, J.*;?Yao, J.; Rong, M. Role of Ion Channels in Pain. Front Pharmacol 2022, 13, 884665.
(19) Zhong, C.; Zhao, H.; Xie, X.; Qi, Z.; Li, Y.; Jia, L.*; Zhang, J.*;?Lu, Y.*?Protein Kinase C-Mediated Hyperphosphorylation and Lateralization of Connexin 43 Are Involved in Autoimmune Myocarditis-Induced Prolongation of QRS Complex. Front Physiol 2022, 13.
(20) Salihu, S.; Meor Azlan, N.; Josiah, S.; Wu, Z.; Wang, Y.; Zhang, J.*?Role of the cation-chloride-cotransporters in the circadian system. Asian J Pharm Sci 2020, 16?(5), 589-597.
(21) Chen, Z.; Zhang, J.; Murillo-de-Ozores, A. R.; Castaneda-Bueno, M.; D'Amico, F.; Heilig, R.; Manning, C. E.; Sorrell, F. J.; D'Angiolella, V.; Fischer, R.; et al. Sequence and structural variations determining the recruitment of WNK kinases to the KLHL3 E3 ligase. Biochem J 2022, 479?(5), 661-675.
(22) Zhang, J.*; Zeng, R.; Labes, A. Marine Microbial-Derived Molecules and Their Potential Medical and Cosmetic Applications. Front Microbiol 2021, 12.
(23) Bertoni, A.; Schaller, F.; Tyzio, R.; Gaillard, S.; Santini, F.; Xolin, M.; Diabira, D.; Vaidyanathan, R.; Matarazzo, V.; Medina, I.; Zhang, J.; et al. Oxytocin administration in neonates shapes hippocampal circuitry and restores social behavior in a mouse model of autism. Mol Psychiatry 2021, 26?(12), 7582-7595.
(24) Meor Azlan, N. F.; Koeners, M. P.; Zhang, J.*?Regulatory control of the Na+-Cl-?co-transporter NCC and its therapeutic potential for hypertension. Acta Pharm Sin B 2021, 11?(5), 1117-1128.
(25) Brown, A.; Meor Azlan, N. F.; Wu, Z.; Zhang, J.*?WNK-SPAK/OSR1-NCC kinase signaling pathway as a novel target for the treatment of salt-sensitive hypertension. Acta Pharmacol Sin 2021, 42?(4), 508-517.
(26) Josiah, S. S.; Meor Azlan, N. F.; Zhang, J.*?Targeting the WNK-SPAK/OSR1 pathway and cation-chloride cotransporters for the therapy of stroke. Int J Mol Sci 2021, 22?(3), 1232.
(27) Meor Azlan, N. F.; Zhang, J.*?Role of the cation-chloride-cotransporters in cardiovascular disease. Cells 2020, 9?(10), 2293.
(28) Andrews, K.; Josiah, S. S.; Zhang, J.*?The therapeutic potential of neuronal K+-Cl-?co-transporter KCC2 in Huntington's disease and its comorbidities. Int J Mol Sci 2020, 21?(23), 9142.
(29) Zhang, J.; Cordshagen, A.; Medina, I.; Nothwang, H. G.; Wisniewski, J. R.; Winklhofer, M.; Hartmann, A. M. Staurosporine and NEM mainly impair WNK-SPAK/OSR1 mediated phosphorylation of KCC2 and NKCC1. PLoS One 2020, 15?(5), e0232967.
(30) Zhang, J.*; Bhuiyan, M. I. H.; Zhang, T.; Karimy, J. K.; Wu, Z.; Fiesler, V. M.; Zhang, J.; Huang, H.; Hasan, M. N.; Skrzypiec, A. E.; et al. Modulation of brain cation-Cl(-) cotransport via the SPAK kinase inhibitor ZT-1a. Nat Commun 2020, 11?(1), 78.
(31) Watanabe, M.#; Zhang, J.#;?Mansuri, M. S.; Duan, J.; Karimy, J. K.; Delpire, E.; Alper, S. L.; Lifton, R. P.; Fukuda, A.; Kahle, K. T. Developmentally regulated KCC2 phosphorylation is essential for dynamic GABA-mediated inhibition and survival. Sci Signal 2019, 12?(603), eaaw9315.
(32) Pisella, L. I.; Gaiarsa, J. L.; Diabira, D.; Zhang, J.;?Khalilov, I.; Duan, J.; Kahle, K. T.; Medina, I. Impaired regulation of KCC2 phosphorylation leads to neuronal network dysfunction and neurodevelopmental pathology. Sci Signal 2019, 12?(603), eaay0300.
(33) Duran, D.; Zeng, X.; Jin, S. C.; Choi, J.; Nelson-Williams, C.; Yatsula, B.; Gaillard, J.; Furey, C. G.; Lu, Q.; Timberlake, A. T.; Zhang, J.; et al. Mutations in Chromatin Modifier and Ephrin Signaling Genes in Vein of Galen Malformation. Neuron 2019, 101?(3), 429-443.e424.
(34) Dumon, C.; Diabira, D.; Chudotvorova, I.; Bader, F.; Sahin, S.; Zhang, J.; Porcher, C.; Wayman, G.; Medina, I.; Gaiarsa, J. L. The adipocyte hormone leptin sets the emergence of hippocampal inhibition in mice. Elife 2018, 7.
(35) Zhang, J.*; Karimy, J. K.; Delpire, E.; Kahle, K. T*. Pharmacological targeting of SPAK kinase in disorders of impaired epithelial transport. Expert Opin Ther Targets 2017, 21?(8), 795-804.
(36) Karimy, J. K. #; Zhang, J. #;?Kurland, D. B.; Theriault, B. C.; Duran, D.; Stokum, J. A.; Furey, C. G.; Zhou, X.; Mansuri, M. S.; Montejo, J.; et al. Inflammation-dependent cerebrospinal fluid hypersecretion by the choroid plexus epithelium in posthemorrhagic hydrocephalus. Nat Med 2017, 23?(8), 997-1003.
(37) Heubl, M.; Zhang, J.;?Pressey, J. C.; Al Awabdh, S.; Renner, M.; Gomez-Castro, F.; Moutkine, I.; Eugene, E.; Russeau, M.; Kahle, K. T.; et al. GABAA?receptor dependent synaptic inhibition rapidly tunes KCC2 activity via the Cl(-)-sensitive WNK1 kinase. Nat Commun 2017, 8?(1), 1776.
(38) Zhang, J.;?Burgess, J. G. Enhanced eicosapentaenoic acid production by a new deep-sea marine bacterium Shewanella electrodiphila?MAR441T. PLoS One 2017, 12?(11), e0188081.
(39) Shekarabi, M.; Zhang, J.;?Khanna, A. R.; Ellison, D. H.; Delpire, E.; Kahle, K. T. WNK Kinase Signaling in Ion Homeostasis and Human Disease. Cell Metab 2017, 25?(2), 285-299.
(40) Kahle, K. T.; Schmouth, J. F.; Lavastre, V.; Latremoliere, A.; Zhang, J.;?Andrews, N.; Omura, T.; Laganiere, J.; Rochefort, D.; Hince, P.; et al. Inhibition of the kinase WNK1/HSN2 ameliorates neuropathic pain by restoring GABA inhibition. Sci Signal 2016, 9?(421), ra32.
(41) Zhang, J.*; Gao, G.; Begum, G.; Wang, J.; Khanna, A. R.; Shmukler, B. E.; Daubner, G. M.; de Los Heros, P.; Davies, P.; Varghese, J.; et al. Functional kinomics establishes a critical node of volume-sensitive cation-Cl(-) cotransporter regulation in the mammalian brain. Sci Rep 2016, 6, 35986.
(42) Zhang, J.; Deng, X.; Kahle, K. T. Leveraging unique structural characteristics of WNK kinases to achieve therapeutic inhibition. Sci Signal 2016, 9?(450), e3.
(43) Kahle, K. T.; Flores, B.; Bharucha-Goebel, D.; Zhang, J.;?Donkervoort, S.; Hegde, M.; Hussain, G.; Duran, D.; Liang, B.; Sun, D.; et al. Peripheral motor neuropathy is associated with defective kinase regulation of the KCC3 cotransporter. Sci Signal 2016, 9?(439), ra77.
(44) Zhang, J.*; Siew, K.; Macartney, T.; O'Shaughnessy, K. M.; Alessi, D. R. Critical role of the SPAK protein kinase CCT domain in controlling blood pressure. Hum Mol Genet 2015, 24?(16), 4545-4558.
(45) Kazlauskaite, A.; Martínez-Torres, R. J.; Wilkie, S.; Kumar, A.; Peltier, J.; Gonzalez, A.; Johnson, C.; Zhang, J.;?Hope, A. G.; Peggie, M.; et al. Binding to serine 65-phosphorylated ubiquitin primes Parkin for optimal PINK1-dependent phosphorylation and activation. EMBO Rep 2015, 16?(8), 939-954.
(46) Hatcher, J. M.; Zhang, J.; Choi, H. G.; Ito, G.; Alessi, D. R.; Gray, N. S. Discovery of a Pyrrolopyrimidine (JH-II-127), a Highly Potent, Selective, and Brain Penetrant LRRK2 Inhibitor. ACS Med Chem Lett 2015, 6?(5), 584-589.
(47) Friedel, P.#; Kahle, K. T.#; Zhang, J.#; Hertz, N.; Pisella, L. I.; Buhler, E.; Schaller, F.; Duan, J.; Khanna, A. R.; Bishop, P. N.; et al. WNK1-regulated inhibitory phosphorylation of the KCC2 cotransporter maintains the depolarizing action of GABA in immature neurons. Sci Signal 2015, 8?(383), ra65.
(48) Schumacher, F. R.#; Siew, K.#; Zhang, J.; Johnson, C.; Wood, N.; Cleary, S. E.; Al Maskari, R. S.; Ferryman, J. T.; Hardege, I.; Yasmin; et al. Characterisation of the Cullin-3 mutation that causes a severe form of familial hypertension and hyperkalaemia. EMBO Mol Med 2015, 7?(10), 1285-1306. DOI: 10.15252/emmm.201505444.
(49) Zhang, J.;?Burgess, J. G. Shewanella electrodiphila?sp. nov., a psychrotolerant bacterium isolated from Mid-Atlantic Ridge deep-sea sediments. Int J Syst Evol Microbiol 2015, 65?(9), 2882-2889.
(50) de Los Heros, P.; Alessi, D. R.; Gourlay, R.; Campbell, D. G.; Deak, M.; Macartney, T. J.; Kahle, K. T.; Zhang, J.*?The WNK-regulated SPAK/OSR1 kinases directly phosphorylate and inhibit the K+-Cl-?co-transporters. Biochem J 2014, 458?(3), 559-573.
(51) Alessi, D. R.; Zhang, J.; Khanna, A.; Hochdorfer, T.; Shang, Y.; Kahle, K. T. The WNK-SPAK/OSR1 pathway: Master regulator of cation-chloride cotransporters. Sci Signal 2014, 7?(334), re3.
(52) Choi, H. G.#; Zhang, J.#;?Deng, X.#; Hatcher, J. M.; Patricelli, M. P.; Zhao, Z.; Alessi, D. R.; Gray, N. S. Brain Penetrant LRRK2 Inhibitor. ACS Med Chem Lett 2012, 3?(8), 658-662.
(53) Zhang, J.; Deng, X.; Choi, HG.; Alessi, DR.; Gray, NS. Characterization of TAE684 as a potent LRRK2 kinase inhibitor. Bioorg Med Chem Lett 2012, 22?(5), 1864-1869.
(54) Zhang, J.; Zhang, E.; Scott, K.; Burgess, J. G. Enhanced electricity production by use of reconstituted artificial consortia of estuarine bacteria grown as biofilms. Environ Sci Technol 2012, 46?(5), 2984-2992.
(55) Zhang, J.*;?Zeng, R. Molecular cloning and expression of an extracellular α-amylase gene from an Antarctic deep sea psychrotolerant Pseudomonas stutzeri?strain 7193. World J Microbiol Biotechnol 2011, 27?(4), 841-850.
(56) Zhang, J.; Zeng, R. Purification and characterization of a cold-adapted alpha-amylase produced by Nocardiopsis?sp. 7326 isolated from Prydz Bay, Antarctic. Mar Biotechnol (New York, N.Y.) 2008, 10?(1), 75-82.
(57) Zhang, J.; Zeng, R. Molecular cloning and expression of a cold-adapted lipase gene from an Antarctic deep sea psychrotrophic bacterium Pseudomonas sp. 7323. Mar Biotechnol (New York, N.Y.) 2008, 10?(5), 612-621.
(58) Zhang, J.; Zeng, R. Psychrotrophic amylolytic bacteria from deep-sea sediment of Prydz Bay, Antarctic: diversity and characterization of amylases. World J Microbiol Biotechnol 2007, 23?(11), 1551-1557
(59) Zhang, J.; Lin, S.; Zeng, R. Cloning, expression, and characterization of a cold-adapted lipase gene from an antarctic deep-sea psychrotrophic bacterium, Psychrobacter?sp 7195. J Microbiol Biotechnol 2007, 17?(4), 604-610. ?From NLM.
(60) Zhang, J.*; Zeng, R.* Cloning, expression and characterization of the cold Active lipase (Lip3) from metagenomic DNA of an Antarctic deep-sea sediment. Prog Biochem Biophys 2006, 33?(12), 1207-1214.
中國科學(xué)院相關(guān)人才計(jì)劃項(xiàng)目（2024-2026）
國家相關(guān)人才計(jì)劃項(xiàng)目（2024-2026）
國家自然科學(xué)基金面上項(xiàng)目（2022-2025）
國家自然科學(xué)基金-英國皇家學(xué)會(huì)國際交流項(xiàng)目 （2021-2022）
國家自然科學(xué)基金面上項(xiàng)目（2020-2023）
